Evaluation of the effectness of kestose in unresectable pancreatic cancer - Evaluation of the effectness of kestose in unresectable pancreatic cancer

Hirooka Yoshiki0 个研究点目标入组 40 人开始时间: 2021年3月10日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Patients who have received sufficient explanation before participating in this study, and have obtained written consent by their own free will with sufficient understanding. 2. Patients aged 20 to 80 at the time of consent. 3. Patients diagnosed with pancreatic cancer based on the diagnostic criteria for pancreatic cancer. 4. Patients with ECOG Performance Status (PS) 0-1.

•1. Patients who have previously undergone gastrointestinal surgery.
•2. Patients who have been receiving radiation therapy or chemotherapy.
•3. Other patients who are judged to be inappropriate by the investigator and the investigator.

发起方

Hirooka Yoshiki